文献速递脑血管病外科神经重症

八十岁及以上动脉瘤性蛛网膜下腔出血患者的治疗:17年单中心分析

Treatment of octogenarians and nonagenarians with aneurysmal subarachnoid hemorrhage: a 17-year institutional analysis.
PubMed 文献 · Acta Neurochir (Wien) · 2021-09-28

该研究回顾性分析了2003年至2019年间一家机构治疗的1418例动脉瘤性蛛网膜下腔出血患者,重点比较80岁以下与80岁及以上患者的神经功能结局。结果显示年龄与功能独立性的下降强烈相关,80岁及以上患者死亡率及不良神经功能结局风险更高,且该组中仅4例结局良好,均为血管内治疗且无基础合并症。

要点

  • 年龄是aSAH后功能结局和死亡率的显著预后指标。
  • 80岁及以上患者多数将遗留严重残疾或死亡。
  • 80岁及以上患者更倾向于接受血管内治疗而非开颅手术。

核心结论

  • 年龄是aSAH后功能结局和死亡率的显著预后指标。
  • 大多数80岁及以上的aSAH患者将遗留严重残疾或死亡。

研究设计与样本

  • 回顾性分析2003年1月1日至2019年7月31日在Barrow神经病学研究所治疗的所有aSAH患者。
  • 按年龄分为<80岁组与≥80岁组,并对≥80岁组进一步比较治疗方式。
  • 共1418例患者,平均年龄55.1(标准差13.6)岁,平均随访24.6(标准差40.0)个月。

主要发现

  • 随访时功能独立(mRS 0-2)率为54%(751/1395)。
  • Logistic回归分析显示年龄增长与功能独立性下降强烈相关(R2=0.929,p<0.001)。
  • 与年轻患者相比,≥80岁患者随访时死亡和不良神经功能结局风险增加。
  • ≥80岁组中仅4例结局良好,均无基础合并症且均接受血管内治疗。

关键数值与推荐

  • 不良神经功能结局定义为改良Rankin量表(mRS)评分>2。
  • 功能独立定义为mRS 0-2。

临床怎么用

  • 对80岁及以上aSAH患者,应充分告知其多数将遗留严重残疾或死亡的高风险。
  • 血管内治疗是该年龄段患者更常采用的治疗方式,但需结合个体情况综合决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Outcomes for octogenarians and nonagenarians after an aneurysmal subarachnoid hemorrhage (aSAH) are particularly ominous, with mortality rates well above 50%. The present analysis examines the neurologic outcomes of patients ≥ 80 years of age treated for aSAH. METHOD: A retrospective review was performed of all aSAH patients treated at Barrow Neurological Institute from January 1, 2003, to July 31, 2019. Patients were placed in 2 groups by age, < 80 vs ≥ 80 years. The ≥ 80-year-old group of octogenarians and nonagenarians was subsequently analyzed to compare treatment modalities. Poor neurologic outcome was defined as a modified Rankin Scale (mRS) score of > 2. RESULTS: During the study period, 1418 patients were treated for aSAH. The mean (standard deviation) age was 55.1 (13.6) years, the mean follow-up was 24.6 (40.0) months, and the rate of functional independence (mRS 0-2) at follow-up was 54% (751/1395). Logistic regression analysis found increasing age strongly associated with declining functional independence (R2 = 0.929, p < 0.001). Forty-three patients ≥ 80 years old were significantly more likely to be managed endovascularly than with open microsurgery (67% [n = 29] vs 33% [n = 14], p < 0.001). Compared with younger patients, those ≥ 80 years old had an increased risk of mortality and poor neurologic outcomes at follow-up. In the ≥ 80-year-old group, only 4 patients had good outcomes; none of the 4 had preexisting comorbidities, and all 4 were treated endovascularly. CONCLUSIONS: Age is a significant prognostic indicator of functional outcomes and mortality after aSAH. Most octogenarians and nonagenarians with aSAH will become severely disabled or die.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Catapano JS, Rumalla K, Srinivasan VM, et al. Treatment of octogenarians and nonagenarians with aneurysmal subarachnoid hemorrhage: a 17-year institutional analysis. Acta Neurochir (Wien). 2021. PMID: 34580755. doi:10.1007/s00701-021-04985-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。